A detailed history of Ronald Blue Trust, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 91 shares of IOVA stock, worth $1,003. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91
Previous 42 116.67%
Holding current value
$1,003
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$7.28 - $11.9 $356 - $583
49 Added 116.67%
91 $0
Q2 2024

Jul 18, 2024

BUY
$7.78 - $14.19 $326 - $595
42 New
42 $0
Q3 2022

Oct 21, 2022

BUY
$9.53 - $13.11 $581 - $799
61 New
61 $1,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.